CNS Pharmaceuticals, Inc. (CNSP) — Institutional Holders, Q2 2026
11 institutional investment managers reported a CNSP position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $7.6M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
CNSP in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Stonepine Capital ManagementAdded · +1,284,921 sh+$6.1M
- Ikarian CapitalAdded · +90,000 sh+$430.2K
- ADAR1 Capital ManagementNew · +70,000 sh+$334.6K
- VANGUARD FIDUCIARYNew · +10,226 sh+$48.9K
- VANGUARD CAPITAL MANAGEMENTNew · +6,993 sh+$33.4K
Biggest sellers
- GEODE CAPITAL MANAGEMENTSold out · -23,189 sh-$110.8K
- Tower Research Capital (TRC)Trimmed · -511 sh-$2.4K
- MAI Capital ManagementSold out · -3 sh-$14.00
- Caitong International Asset Management , LtdSold out · -1 sh-$5.00
- CITIGROUPSold out · -1 sh-$5.00
CNSP 13F holders ranked 1–11 of 11
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Stonepine Capital Management#1 · 1,345,921 sh | 1,345,921 | $6.4M | 3.01% | +2106.4% |
| 2 | Ikarian Capital#2 · 135,830 sh | 135,830 | $649.3K | 0.07% | +196.4% |
| 3 | ADAR1 Capital Management#3 · 70,000 sh | 70,000 | $334.6K | 0.02% | New |
| 4 | BOOTHBAY FUND MANAGEMENT#4 · 13,524 sh | 13,524 | $64.6K | <0.01% | 0.0% |
| 5 | VANGUARD FIDUCIARY#5 · 10,226 sh | 10,226 | $48.9K | 0.00% | New |
| 6 | VANGUARD CAPITAL MANAGEMENT#6 · 6,993 sh | 6,993 | $33.4K | 0.00% | New |
| 7 | UBS Group AG#7 · 1,461 sh | 1,461 | $7.0K | 0.00% | +100.4% |
| 8 | Tower Research Capital (TRC)#8 · 799 sh | 799 | $3.8K | <0.01% | -39.0% |
| 9 | BARCLAYS PLC#9 · 19 sh | 19 | $91.00 | 0.00% | New |
| 10 | BARRETT & COMPANY#10 · 8 sh | 8 | $38.00 | — | 0.0% |
| 11 | DANSKE BANK A/S#11 · 1 sh | 1 | $5.00 | 0.00% | 0.0% |
Funds that sold out of CNSP in Q2 2026 (4)
Held CNSP at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| GEODE CAPITAL MANAGEMENT23,189 sh | 23,189 | $55.7K |
| MAI Capital Management3 sh | 3 | $8.00 |
| Caitong International Asset Management , Ltd1 sh | 1 | $2.00 |
| CITIGROUP1 sh | 1 | $2.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.